Nektar Therapeutics Announced Several Presentations For Rezpegaldesleukin At The 2024 European Academy Of Dermatology And Venereology Congress
Nektar Therapeutics Announced Several Presentations For Rezpegaldesleukin At The 2024 European Academy Of Dermatology And Venereology Congress
內克塔治療宣佈將在2024年歐洲皮膚病學和性病學學院大會上針對Rezpegaldesleukin進行多個報告。
Nektar Therapeutics Announced Several Presentations For Rezpegaldesleukin At The 2024 European Academy Of Dermatology And Venereology Congress
內克塔治療宣佈將在2024年歐洲皮膚病學和性病學學院大會上針對Rezpegaldesleukin進行多個報告。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。